Capital International, Inc. Royalty Pharma PLC Transaction History

Capital International, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $21.6 Million - $26.1 Million	-614,131 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $8.09 Million - $9.46 Million	-223,943 Reduced 26.72%	614,131 $22.2 Million
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $2.3 Million - $2.69 Million	-57,611 Reduced 6.43%	838,074 $34.4 Million
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $5.61 Million - $7 Million	-132,490 Reduced 12.89%	895,685 $39.1 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $1.59 Million - $2.2 Million	44,001 Added 4.47%	1,028,175 $51.5 Million
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $16.3 Million - $20.4 Million	421,574 Added 74.93%	984,174 $41.4 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $25 Million - $29.3 Million	562,600 New	562,600 $27.3 Million

404

291M

305K

138K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.